Posts

Strategic by Nature: How Nabil Lally Drives Pharma Success

  In an industry where innovation alone is not enough, Nabil Lally brings a rare and essential blend of scientific expertise and strategic thinking to the world of drug development. As Senior Director of Business Development at Quotient Sciences , Nabil has built a reputation for delivering real results by combining deep technical knowledge with an instinct for collaboration and forward-thinking execution. At the core of Nabil’s work is a commitment to accelerating the development of new therapies without compromising quality. He plays a leading role in promoting Translational Pharmaceutics® , Quotient Sciences’ unique integrated platform that unites formulation development, GMP manufacturing, and clinical testing within a single streamlined process. This approach enables companies to gather real-time clinical data and make adaptive decisions faster than traditional models allow, shaving up to 12 months off development timelines. But what makes Nabil a standout leader is not ju...

A Son’s Farewell: Nabil Lally Honors His Mother’s Legacy

Image
  I share a tribute to my Mom who just passed, to honor her legacy.  A Mothers Day Tribute I couldnt make it this time, I couldnt save her. But she was ready to go, she told me so. Instead of surprising her with roses today, I bought a casket. But it's a pretty one. Purple. Her life is one to be remembered, not just on Mothers Day. I have played Dr for 30 years, first diagnosing her heart attack in 1995. Then the blocked artery, the stent, the angioplasty, the fractured eye socket, the Covid, the Congestive heart failure, the multiple strokes, the rehab. I fought for her, like she fought for me, like she fought for her students.  Hundreds, nay, thousands of people touched by her light, transformed by her steadfastness and love of God. If you have been impacted by her or wish to learn why she had such a calling, you all are welcome, the door is always open.  She had a childhood learning diasability and was socially passed to high school.  She became an educator i...

Nabil Lally Represent Quotient Sciences at ASCPT 2025

Image
  The American Society for Clinical Pharmacology and Therapeutics (ASCPT) 2025 Annual Meeting  in Washington, D.C. marked another significant milestone in the evolution of translational medicine. Gathering researchers, clinicians, and leaders from across the globe, ASCPT 2025 served as a dynamic forum for scientific exchange, collaboration, and insights into the future of drug development. Representing Quotient Sciences , Nabil Lally , Senior Director of Business Development, and Dr . Andreas Reichl , Senior Drug Development Consultant, brought cutting-edge perspectives to this pivotal event.   Their participation underscored Quotient Sciences’ commitment to transforming the traditional drug development pathway through its integrated Translational Pharmaceutics    platform and consultative, science-led approach to clinical pharmacology. Setting the Stage: Why ASCPT Matters ASCPT is widely recognized as the premier scientific conference in clinical pharmacology, ...